University of California San Francisco

Dr. Garrett Roll large headshot
Garrett
Roll
MD

Associate Professor of Surgery
Division of Transplant Surgery

Address

35 Medical Center Way, #001
San Francisco, CA 94143
United States

    Biography

    Dr. Roll completed both general surgery training and the abdominal organ transplant fellowship at the University of California San Francisco. During his training, Dr. Roll spent 2 years in Dr. Holger Willenbring's laboratory investigating liver cell therapy, as well as normal and pathologic liver regeneration. After fellowship Dr. Roll moved to England to become a Senior International Fellow in Liver Transplant and Multi Organ Procurement at Queen Elizabeth Hospital, Birmingham, one of the busiest liver transplant departments in the United Kingdom. There he gained valuable experience in the blossoming field of DCD liver transplant and normothermic machine liver perfusion prior to returning to UCSF.

    Since returning to UCSF in 2015, Dr. Roll has specialized in abdominal organ transplantation for both adults and children, including liver and kidney transplant surgery from living donors, complex hepatobiliary surgery, and kidney autotransplants for intractable ureteral problems. He also performs general surgery in patients with end-stage organ disease and patients taking immunosuppression. His expertise includes using minimally invasive surgical techniques.

    Within UCSF, Dr. Roll is an investigator on several clinical trials looking at outcomes for organ transplant recipients and advance organ preservation. He has leadership roles in patient safety and quality improvement at UCSF, in addition to teaching medical students and residents in multiple forums. Outside of UCSF, he serves on the editorial board of multiple peer reviewed journals.

    Education

    Education

    Boston College, BS, Finance, 1995-1999
    Brandeis University, Post Baccalaureate, Premedical, 1999-2001
    Temple University School of Medicine, MD, 2001-2005

    Residencies

    University of California, San Francisco, General Surgery, 2005-2012

    Fellowships
    Abdominal Transplant
    Start Year
    2012
    End Year
    2014

    Board Certifications

    American Board of Surgery, General Surgery

    Clinical Expertise

    Ascites

    Bile Duct Cancer (Cholangiocarcinoma)

    Bile Duct Injuries

    Bile Duct Strictures

    Bridging Therapies to Downstage HCC in Liver Transplant Setting

    Choledochal Cysts

    Deceased Donor Organ Utilization

    Gallbladder Cancer

    Kidney Transplantation

    Laparoscopic Donor Nephrectomy

    Liver Biopsy

    Hepatocellular Carcinoma (Primary Liver Cancer)

    Liver Cysts

    Liver Metastases (Secondary Liver Cancer)

    Liver Resection

    Liver Transplantation

    Living Donor Kidney Transplantation

    Living Donor Liver Transplantation

    Normothetic Machine Liver Perfusion

    Organ Donation of Cardiovascular Death

    Pancreas Transplantation

    Pediatric Kidney Transplantation

    Pediatric Liver Transplantation

    Portal Hypertension

    Clinical Interests

    Transplantation
    HBP surgery

    Clinical Trials

    1. Related Conditions: Liver Transplant| Start Date: | End Date:
    2. Related Conditions: HIV/AIDS, Kidney Transplant| Start Date: | End Date:

    In the News

    October, 16, 2015 | UCSF Transplant Surgery

    Research Interests

    Cell therapy with hepatocytes and hepatocyte-like cells derived from stem cells.
    Role of miRNA in liver regeneration

    Normothetic machine liver perfusion

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 117
    1. Steroid Avoidance After Adult Living Donor Liver Transplant: A Cohort Analysis.
      Nunez M, Praglin CR, Torres AM, Agudelo EZ, Braun HJ, Huang CY, Syed S, Roberts JP, Roll GR| | PubMed
    2. Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference.
      Sturdevant M, Ganesh S, Samstein B, Verna EC, Rodriguez-Davalos M, Kumar V, Abouljoud M, Andacoglu O, Askar M, Broering D, Emamaullee J, Emond JC, Haugen CE, Jesse MT, Kasahara M, Liapakis A, Mandelbrot D, Pillai A, Roll GR, Selzner N, Emre S, AST LDLT Consensus Conference Working Group| | PubMed
    3. COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.
      Roll GR, Bray RA, Cooper M, Eagar TN, Gebel HM, Vranic GM, Hitchman KMK, Houp J, Kamoun M, Killian J, Kim J, Kumar V, Levine M, Lovasik BP, Lunow-Luke T, Parsons RF, Pattanayak V, Ranch D, Shah A, Stock PG, Timofeeva OA, Trofe-Clark J, Wongjirad C, Yeh H, Yi S, Rajalingam R| | PubMed
    4. Number of Local Regional Therapies for Hepatocellular Carcinoma and Peri-Operative Outcomes after Liver Transplantation.
      Brown AE, Shui AM, Adelmann D, Mehta N, Roll GR, Hirose R, Syed SM| | PubMed
    5. Simultaneous thoracic and abdominal donation after circulatory death organ recovery: the abdominal surgeon's perspective.
      Thiessen C, Wisel SA, Roll GR| | PubMed
    6. Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study.
      Meier RPH, Kelly Y, Braun H, Maluf D, Freise C, Ascher N, Roberts J, Roll G| | PubMed
    7. Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.
      Killian AC, Reed RD, McLeod MC, MacLennan PA, Kumar V, Pittman SE, Maynor AG, Stanford LA, Baker GA, Schinstock CA, Silkensen JR, Roll GR, Segev DL, Orandi BJ, Lewis CE, Locke JE| | PubMed
    8. Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations.
      Roll GR, Spiro M, Raptis DA, Jalal A, Yan CT, Olthoff KM, Caicedo JC, Lee KW, Yagi S, Cattral MS, Soin AS, ERAS4OLT.org Working Group| | PubMed
    9. 214.1: Strategies to Achieve Long-term Insulin Independence Using a Multimodal Approach to Beta-cell Replacement in Patients With Type I Diabetes.
      Steven Wisel, Miguel Nunez, James M Gardner, Giulia Worner, Garrett R Roll, Shareef M Syed, Gregory Szot, Medhi Tokhol, Kristina Johnson, Umesh Masharani, Andrew M Posselt, Peter G Stock| | UCSF Research Profile
    10. 335.4: Use of Donation After Circulatory Death Donors for High Model for End-Stage Liver Disease Recipients.
      Raphael Meier, Miguel Nunez, Shareef Syed, Chris Freise, John Roberts, Nancy Ascher, Ryutaro Hirose, Garrett Roll| | UCSF Research Profile